Waldaschaff is involved in industrial services and products. It offers various products and services to its markets.

Waldaschaff

Luoyang Jiangtai is a Chinese manufacturer specializing in refractory materials and industrial furnace equipment.

Luoyang Jiangtai

ATOSS provides workforce management applications and solutions.

ATOSS

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Metric
Company Name	Waldaschaff	Luoyang Jiangtai	ATOSS	Bayer Aktiengesellschaft
Symbol				BAYN
MSH ID	COM:WALDASCHAFF	CN:COM:LYJT	COM:ATOSS	COM:BAYER
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Commercial & Professional Services	Basic Materials & Materials	Technology	Healthcare
Industry	Manufacturing	Industrial Manufacturing	Software	Drug Manufacturers - General
Country	DE	CN	DE	DE
Stage
Employee Count			501	98.19K
Website	waldaschaff.com	lyjt.com.cn	atoss.com	bayer.com
LinkedIn	waldaschaff	lingyun-industrial-corporation-limited	atoss-software	bayer
Founders

Metric
Market Cap				27.44B
Enterprise Value
Monthly Web Traffic	222	2.06K	644.72K
Web Traffic Growth	1.29	-0.83	0.12
Valuation
Raised Capital

Metric
Revenue				50.32B
Revenue (LTM)
Revenue (NTM)
Gross Profit				29.46B
EBITDA				13.04B
Operating Income				8.88B
Net Income				-3.11B
EPS				-3.16
Diluted EPS				-3.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.59
Operating Profit Margin				0.08
EBITDA Margin				0.26
Net Profit Margin				-0.03
Return on Equity				-0.04
Return on Assets				-0.01
Return on Capital Employed				0.04

WALD

COM:WALDASCHAFF

Waldaschaff

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-7.66
P/B Ratio				0.84
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				0.63
EV Multiple				-0.89

Metric
Days Sales Outstanding
Days Payables Outstanding				118.44
Days Inventory Outstanding				257.77
Operating Cycle				389.93
Cash Conversion Cycle				270.05
Asset Turnover				0.39

Metric
Operating Cash Flow				4.29B
Free Cash Flow				1.38B
Cash Flow to Debt				0.16
Operating Cash Flow/Sales				0.16
Free Cash Flow Yield				-0.02

Metric
Cash & Equivalents				6.24B
Accounts Receivable				727.74M
Inventory				14.73B
Goodwill				34.12B
Debt to Capitalization				0.57
Debt to Assets				0.41
Current Ratio				1.13
Quick Ratio				0.87

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue				0.12
SG&A to Revenue				0.05